CT
CytomX Therapeutics, Inc.
CTMX · NASDAQ
$3.65 +0.69% (+$0.02)
1M +6.10%
Market Cap $794.6M
P/E Ratio -
Div. Yield -
ROE 38.46%
Bulios Fair Price
$3.11
14.8% downside
Trenutna cena
$3.65
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CTMX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
37 /100
Fair P/S 43.42x
P/B 2.63x
P/E N/A
Growth
78 /100
Growing Rev. growth 12.75%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 98.63%
Net margin 435.22%
Op. margin 476.19%
Quality
1 /100
Poor ROIC 25.49%
ROE 38.46%
ROA 20.89%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 9.36x
Int. coverage N/A
Stability
1 /100
Unstable Beta 2.14x
Rev. volatility 68.06%
EPS volatility 2,920.99%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CTMX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sean A. McCarthy
Employees
69
Headquarters
South San Francisco
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report